Thirty-six people have been documented to have contracted the rare blood condition called immune thrombocytopenia (ITP) following the vaccination with vaccines from Pfizer and BioNTech or Moderna.
The cases of these people were reported to the Vaccine Adverse Event Reporting System (VAERS), a governmental body responsible for the monitoring of how different medicines affect their recipients.
What is ITP? The doctor who received the vaccine died.
ITP is a disease characterized by the lack of adequate blood clotting caused by the immune attack on platelets.
Besides low platelet count, the condition is accompanied by symptoms such as bleeding and bruising.
Dr. Gregory Michael, an obstetrician from Miami Beach, is one of the people who developed ITP after inoculation with the Pfizer jab.
He started to notice the first symptoms of the disorder three days after he received the vaccine.
Soon after that, Michael was admitted to the intensive care unit.
According to his wife Heidi Neckelmann, the treatment failed and Michael died from a brain hemorrhage after spending two weeks in a hospital.
Neckelmann described her late husband as a pro-vaccine 56-year-old who did not have any health issues.
She invited people to be aware that vaccination can have side effects that can ruin the life that was going on entirely peacefully.
On the other hand, Luz Legaspi, a 72-year-old woman from New York, was hospitalized on January 19th, just a day following her Moderna jab vaccination.
Like Michael, she was diagnosed with a low platelet count that signaled ITP.
Fortunately, after about two weeks spent in a hospital, Legaspi managed to come back home with a normalized platelet count.
Pfizer took the news seriously
In response to the reports about ITP cases, Pfizer spokesperson said that the company is aware of the cases and takes them very seriously, stressing that adverse events are expected to occur at the same level they will occur in the general population.
Moderna officials did not offer any response so far.
Dr. James Bussel, an expert in the studies of ITP, told reporters that he and his colleague investigated 15 cases of post-vaccination immune thrombocytopenia.
Bussel said that there is a possibility of a link with COVID-19 vaccination and ITP, but that it has yet to be confirmed.
He added that it is far from clear what would be the causal mechanism responsible for the link.
So far, more than 32 million people have been given at least one dose of the COVID-19 vaccine in the United States. This accounts for almost a tenth of the U.S. population.
On the other hand, it is estimated that a bit less than 1 in 10,000 people in the U.S. suffer from ITP.
For the causation to be established between the vaccine inoculation and ITP, an increase in ITP prevalence among the vaccinated population will likely have to be demonstrated.